Cambridge spinout RegGenome nets £4.6m for regulation data repository
Summary
Regulatory Genome Development, a University of Cambridge spinout, has completed a seed funding round of $6m (£4.6m) led by Evolution Equity Partners. RegGenome uses machine learning to sequence regulatory content and turn it into a structured, machine-readable format that can be accessed via a data repository. RegGenome is primed to deliver a quantum leap in how regulatory content is shared and harnessed,” said Dr Marcio Siqueira, head of physical sciences at Cambridge Enterprises. “Cambridge Enterprise has been an integral part of RegGenome from the outset, from enabling access to the required technology to investing in its funding. “Deepening regulatory intelligence and digitizing compliance and risk management functions utilizing machine learning and interoperability with cybersecurity, fintech and ESG presents a tremendous opportunity for the company.